Efficacy and Safety of Deferasirox in β-Thalassemia Major Patients in Iran: A Prospective Study from a Single referral Center in Iran

2014 ◽  
Vol 31 (1) ◽  
pp. 76-86 ◽  
Author(s):  
Samin Alavi ◽  
Maryam Ebadi ◽  
Farid Ghazizadeh ◽  
Mohammad Taghi Arzanian ◽  
Bibishahin Shamsian ◽  
...  
Keyword(s):  
Prospective Study ◽  
Thalassemia Major ◽  
Efficacy And Safety ◽  
Referral Center ◽  
A Prospective Study

scholarly journals Treatment of Diabetic Foot Infections: A Prospective Study Highlighting the Efficacy and Safety of Moxifloxacin

2018 ◽  
Vol 8 (2-3) ◽  
pp. 32-36 ◽  
Author(s):  
Bikha Ram Devrajani ◽  
Samar Raza ◽  
Rubina Khushik ◽  
Syed Zulfiquar Ali Shah ◽  
Sanam Mari ◽  
...  
Keyword(s):  
Prospective Study ◽  
Diabetic Foot ◽  
Efficacy And Safety ◽  
Diabetic Foot Infections ◽  
A Prospective Study

Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: A prospective study

2009 ◽  
Vol 158 (2) ◽  
pp. 163-169.e3 ◽  
Author(s):  
Craig M. Pratt ◽  
James A. Reiffel ◽  
Kenneth A. Ellenbogen ◽  
Gerald V. Naccarelli ◽  
Peter R. Kowey
Keyword(s):  
Atrial Fibrillation ◽  
Prospective Study ◽  
Ethyl Esters ◽  
Efficacy And Safety ◽  
Omega 3 ◽  
A Prospective Study

scholarly journals PROMPT: a prospective study to assess efficacy and safety of metyrapone in endogenous Cushing's syndrome

2018 ◽  
Author(s):  
Lynnette Nieman ◽  
Baris Akinci ◽  
Albert Beckers ◽  
Marek Bolanowski ◽  
Felicia Alexandra Hanzu ◽  
...  
Keyword(s):  
Prospective Study ◽  
Cushing’S Syndrome ◽  
Cushing's Syndrome ◽  
Efficacy And Safety ◽  
A Prospective Study

scholarly journals The Efficacy and Safety of Uractiv Control in Overactive Bladder Treatment

2020 ◽  
Vol 71 (1) ◽  
pp. 390-394
Author(s):  
Calin Bogdan Chibelean ◽  
Veronica Ghirca ◽  
Razvan-Cosmin Petca ◽  
Daniel Porav-Hodade ◽  
Ioan Alin Nechifor-Boila ◽  
...  
Keyword(s):  
Placebo Group ◽  
Side Effects ◽  
Overactive Bladder ◽  
Prospective Study ◽  
Treatment Option ◽  
Alternative Treatment ◽  
Control Group ◽  
Efficacy And Safety ◽  
A Prospective Study ◽  
Safe Treatment Option

The aim of this study is to evaluate the efficacy and safety of Uractiv Control as an alternative treatment with no side effects in Overactive Bladder (OAB). We performed a prospective study over a period of 15 months (May 2018- September 2019) in Department of Urology from Targu-Mureș. We included 165 patients diagnosed with OAB wet (129 patients) and dry form (36 patients) which were fully evaluated over a 3-month period of treatment. 48 patients were treated with placebo 1 month and were evaluated by the same parameters like Uractiv Control group. The frequency of micturition during the day and night after the treatment with Uractiv Control was improved compared to placebo group (p=0.0001) and also the loss of urine episodes (p=0.03). Patients did not report any significant side effects of the treatment. Uractiv Control represents a safe treatment option with no side effects and improvement of the storage in OAB.

Sign in / Sign up

Export Citation Format

Share Document